Sotirios Kakavas

Dr. Sotirios Kakavas

Intensive Care Unit, Center for Respiratory Failure, “Sotiria” General Hospital of Chest Diseases, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
SKSotirios Kakavas
Sotirios Kakavas
DKDimitrios Karagiannis
Dimitrios Karagiannis
ZBZoi Bouloubasi
Zoi Bouloubasi
Kalliopi-Anna PouliaKalliopi-Anna Poulia
Kalliopi-Anna Poulia
SKSteven Kompogiorgas
Steven Kompogiorgas
VVVasileios Vougas
Vasileios Vougas
Although several studies have reported an association between malnutrition and the risk of severe complications after abdominal surgery, there have been no studies evaluating the use of Global Leadership Initiative on Malnutrition (GLIM) criteria for predicting postoperative pulmonary complications (PPCs) following major abdominal surgery in cancer patients. This study aimed to investigate the association among the diagnosis of malnutrition by GLIM criteria, PPCs risk and 90-day all-cause mortality rate following major abdominal surgery in cancer patients. We prospectively analyzed 218 patients (45% male, mean age 70.6 ± 11.2 years) with gastrointestinal cancer who underwent major abdominal surgery at our hospital between October 2018 and December 2019. Patients were assessed preoperatively using GLIM criteria of malnutrition, and 90-day all-cause mortality and PPCs were recorded. In total, 70 patients (32.1%) were identified as malnourished according to GLIM criteria, of whom 41.1% fulfilled the criteria for moderate and 12.6% for severe malnutrition. PPCs were detected in 48 of 218 patients (22%) who underwent major abdominal surgery. Univariate logistic regression analysis revealed that the diagnosis of malnutrition was significantly associated with the risk of PPCs. Furthermore, in multivariate model analysis adjusted for other clinical confounding factors, malnutrition remained an independent factor associated with the risk of PPCs (RR = 1.82; CI = 1.21–2.73) and 90-day all-cause mortality (RR = 1.97; CI = 1.28–2.63, for severely malnourished patients). In conclusion, preoperative presence of malnutrition, diagnosed by the use of GLIM criteria, is associated with the risk of PPCs and 90-day mortality rate in cancer patients undergoing major abdominal surgery.

Verified
Journal Article
Open access
PDF file
Ioannis PantazopoulosIoannis Pantazopoulos
Ioannis Pantazopoulos
KMKalliopi Magounaki
Kalliopi Magounaki
Ourania S. KotsiouOurania S. Kotsiou
Ourania S. Kotsiou
ERErasmia Rouka
Erasmia Rouka
FPFotis Perlikos
Fotis Perlikos
Konstantinos I. GourgoulianisKonstantinos I. Gourgoulianis
Konstantinos I. Gourgoulianis
Globally, chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality, having a significant socioeconomic effect. Several molecular mechanisms have been related to COPD including chronic inflammation, telomere shortening, and epigenetic modifications. Nowadays, there is an increasing need for novel therapeutic approaches for the management of COPD. These treatment strategies should be based on finding the source of acute exacerbation of COPD episodes and estimating the patient’s own risk. The use of biomarkers and the measurement of their levels in conjunction with COPD exacerbation risk and disease prognosis is considered an encouraging approach. Many types of COPD biomarkers have been identified which include blood protein biomarkers, cellular biomarkers, and protease enzymes. They have been isolated from different sources including peripheral blood, sputum, bronchoalveolar fluid, exhaled air, and genetic material. However, there is still not an exclusive biomarker that is used for the evaluation of COPD but rather a combination of them, and this is attributed to disease complexity. In this review, we summarize the clinical significance of COPD-related biomarkers, their association with disease outcomes, and COPD patients’ management. Finally, we depict the various samples that are used for identifying and measuring these biomarkers.

1 June 2015 in Journal of Infection
Verified
Journal Article
Closed access
SKSotirios Kakavas
Sotirios Kakavas
Nicolas MongardonNicolas Mongardon
Nicolas Mongardon
ACA. Cariou
A. Cariou
AGA. Gulati
A. Gulati
Theodoros XanthosTheodoros Xanthos
Theodoros Xanthos

1 April 2018 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
SKSotirios Kakavas
Sotirios Kakavas
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
DODimitrios Oikonomou
Dimitrios Oikonomou
DKDimitrios Karagiannis
Dimitrios Karagiannis
SMStefano Masi
Stefano Masi
Theodoros XanthosTheodoros Xanthos
Theodoros Xanthos

1 May 1999 in Planta Medica
Verified
Journal Article
Closed access
PDF file
HSHelen Skaltsa
Helen Skaltsa
DLDiamante Lazari
Diamante Lazari
EGEvanthia Georgiadou
Evanthia Georgiadou
SKSotirios Kakavas
Sotirios Kakavas
Theophanis ConstantinidisTheophanis Constantinidis
Theophanis Constantinidis

1 November 2013 in Heart & Lung
Verified
Journal Article
Closed access
SKSotirios Kakavas
Sotirios Kakavas
EBEvangelos Balis
Evangelos Balis
VLVasiliki Lazarou
Vasiliki Lazarou
MKMarousa Kouvela
Marousa Kouvela
GTGeorgios Tatsis
Georgios Tatsis